NSTG / NanoString Technologies, Inc. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

NanoString Technologies, Inc.
US ˙ NasdaqGM ˙ US63009R1095
HINDI NA ACTIVE ANG SIMBONG ITO

Mga Batayang Estadistika
LEI 549300G4CK0Y3WRDMY89
CIK 1401708
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to NanoString Technologies, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
June 26, 2024 S-8 POS

As filed with the Securities and Exchange Commission on June 26, 2024

As filed with the Securities and Exchange Commission on June 26, 2024 Registration No.

June 26, 2024 S-8 POS

As filed with the Securities and Exchange Commission on June 26, 2024

As filed with the Securities and Exchange Commission on June 26, 2024 Registration No.

June 26, 2024 S-3DPOS

As filed with the Securities and Exchange Commission on June 26, 2024

As filed with the Securities and Exchange Commission on June 26, 2024 Registration No.

June 26, 2024 S-8 POS

As filed with the Securities and Exchange Commission on June 26, 2024

As filed with the Securities and Exchange Commission on June 26, 2024 Registration No.

June 26, 2024 S-8 POS

As filed with the Securities and Exchange Commission on June 26, 2024

As filed with the Securities and Exchange Commission on June 26, 2024 Registration No.

June 26, 2024 15-12G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 001-35980 NS Wind Down Co., Inc. (Exact name of registrant as specified in

June 26, 2024 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 26, 2024 NS Wind Down Co., Inc

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 26, 2024 NS Wind Down Co.

June 26, 2024 S-8 POS

As filed with the Securities and Exchange Commission on June 26, 2024

As filed with the Securities and Exchange Commission on June 26, 2024 Registration No.

June 26, 2024 S-8 POS

As filed with the Securities and Exchange Commission on June 26, 2024

As filed with the Securities and Exchange Commission on June 26, 2024 Registration No.

June 26, 2024 S-8 POS

As filed with the Securities and Exchange Commission on June 26, 2024

As filed with the Securities and Exchange Commission on June 26, 2024 Registration No.

June 26, 2024 S-8 POS

As filed with the Securities and Exchange Commission on June 26, 2024

As filed with the Securities and Exchange Commission on June 26, 2024 Registration No.

June 26, 2024 S-8 POS

As filed with the Securities and Exchange Commission on June 26, 2024

As filed with the Securities and Exchange Commission on June 26, 2024 Registration No.

June 26, 2024 S-8 POS

As filed with the Securities and Exchange Commission on June 26, 2024

As filed with the Securities and Exchange Commission on June 26, 2024 Registration No.

June 26, 2024 S-8 POS

As filed with the Securities and Exchange Commission on June 26, 2024

As filed with the Securities and Exchange Commission on June 26, 2024 Registration No.

June 26, 2024 S-8 POS

As filed with the Securities and Exchange Commission on June 26, 2024

As filed with the Securities and Exchange Commission on June 26, 2024 Registration No.

June 26, 2024 S-8 POS

As filed with the Securities and Exchange Commission on June 26, 2024

As filed with the Securities and Exchange Commission on June 26, 2024 Registration No.

June 26, 2024 S-8 POS

As filed with the Securities and Exchange Commission on June 26, 2024

As filed with the Securities and Exchange Commission on June 26, 2024 Registration No.

June 26, 2024 S-8 POS

As filed with the Securities and Exchange Commission on June 26, 2024

As filed with the Securities and Exchange Commission on June 26, 2024 Registration No.

June 20, 2024 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 18, 2024 NS Wind Down Co., Inc

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 18, 2024 NS Wind Down Co.

June 20, 2024 EX-99.1

IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE In re: NANOSTRING TECHNOLOGIES, INC., et al.,1 Debtors. Chapter 11 Case No. 24-10160 (CTG) (Jointly Administered) Ref. Docket Nos. 579, 610, 624 & 641 FINDINGS OF FACT, CONCLUSIONS OF

nstg06182024ex991 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE In re: NANOSTRING TECHNOLOGIES, INC.

May 28, 2024 EX-3.1

STATE OF DELAWARE CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION NANOSTRING TECHNOLOGIES, INC.

EXHIBIT 3.1 STATE OF DELAWARE CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF NANOSTRING TECHNOLOGIES, INC. THE UNDERSIGNED, being a duly appointed and authorized officer of NanoString Technologies, Inc., a corporation organized and existing under and by virtue of the laws of the State of Delaware (the “Corporation”), does hereby certify, on behalf of the Corpo

May 28, 2024 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 22, 2024 NS Wind Down Co., Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 22, 2024 NS Wind Down Co.

May 28, 2024 EX-3.2

SECOND AMENDED AND RESTATED BYLAWS OF NS WIND DOWN CO., INC. (NanoString Technologies, Inc.) (as amended and restated on May 27, 2024) TABLE OF CONTENTS Page ARTICLE I CORPORATE OFFICES 1 1.1 Registered Office 1 1.2 Other Offices 1 ARTICLE II MEETING

EXHIBIT 3.2 SECOND AMENDED AND RESTATED BYLAWS OF NS WIND DOWN CO., INC. (NanoString Technologies, Inc.) (as amended and restated on May 27, 2024) TABLE OF CONTENTS Page ARTICLE I CORPORATE OFFICES 1 1.1 Registered Office 1 1.2 Other Offices 1 ARTICLE II MEETINGS OF STOCKHOLDERS 1 2.1 Place of Meetings 1 2.2 Annual Meeting 1 2.3 Special Meeting 1 2.4 Advance Notice Procedures 2 2.5 Notice of Stock

May 22, 2024 EX-99.1

IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE In re: NANOSTRING TECHNOLOGIES, INC., et al.,1 Debtors. Chapter 11 Case No. 24-10160 (CTG) (Jointly Administered) GLOBAL NOTES TO MONTHLY OPERATING REPORT FOR NANOSTRING TECHNOLOGIES,

IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE In re: NANOSTRING TECHNOLOGIES, INC.

May 22, 2024 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 22, 2024 NanoString Technologies, Inc.

May 17, 2024 SC 13G

NSTGQ / NanoString Technologies, Inc. / Farallon Capital Partners, L.P. Passive Investment

SC 13G 1 nano13g.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ) * NanoString Technologies, Inc. (Name of Issuer) Common Stock, Par Value $0.0001 per share (Title of Class of Securities) 63009R109 (Cusip Number) May 9, 2024 (Date of Event which Requires Filing of this Statement) Check the appropriate

May 10, 2024 NT 10-Q

UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K ý Form 10-Q ¨ Form 10-D ¨ Form N-CEN ¨ Form N-CSR For Period Ended: March 31, 2024 ☐Transition Report on Form 10-K ☐Transition Report on Form 20-F ☐Transition Report on Form 11-K ☐Transition Report on Form 10-Q For the Transi

May 8, 2024 8-K

Material Modification to Rights of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 07, 2024 NanoString Technologies, Inc.

May 6, 2024 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 06, 2024 NanoString Technologies, Inc.

May 6, 2024 EX-99.1

Bruker Completes Asset Acquisition of NanoString Business Adds Highly Complementary Business in Gene Expression Profiling and Spatial Transcriptomics for Discovery and Translational Research

News Exhibit 99.1 Bruker Completes Asset Acquisition of NanoString Business Adds Highly Complementary Business in Gene Expression Profiling and Spatial Transcriptomics for Discovery and Translational Research BILLERICA, Massachusetts – May 6, 2024: Bruker Corporation (Nasdaq: BRKR) today announced that it has closed its asset acquisition of the business of NanoString Technologies, Inc., headquarte

April 22, 2024 EX-99.1

UST Form 11-MOR (12/01/2021) 1 UNITED STATES BANKRUPTCY COURT DISTRICT OFIN THE DELAWARE In Re. NanoString Technologies Germany GmbH Debtor(s) § § § § Case No. 24-10163 Lead Case No. 24-10160 Jointly Administered Monthly Operating Report Chapter 11 R

ex991march2024mors UST Form 11-MOR (12/01/2021) 1 UNITED STATES BANKRUPTCY COURT DISTRICT OFIN THE DELAWARE In Re.

April 22, 2024 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 22, 2024 NanoString Technolog

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 22, 2024 NanoString Technologies, Inc.

April 19, 2024 8-K

Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 17, 2024 NanoString Technologies, Inc.

April 19, 2024 EX-99.1

NanoString Technologies to Be Acquired by Bruker Corporation Bruker Wins Competitive Auction Acquisition Ensures Continued Customer Access to NanoString’s Products Transaction Expected to Close in early-May 2024

Exhibit 99.1 NanoString Technologies to Be Acquired by Bruker Corporation Bruker Wins Competitive Auction Acquisition Ensures Continued Customer Access to NanoString’s Products Transaction Expected to Close in early-May 2024 Seattle, March 10, 2024 – (BUSINESS WIRE) - NanoString Technologies, Inc. (“NanoString” or “the Company”), a leading provider of life science tools for discovery and translati

April 19, 2024 EX-10.1

ASSET PURCHASE AGREEMENT by and between NanoString Technologies, Inc., Bruker Corporation Dated as of April 17, 2024 TABLE OF CONTENTS

Exhibit 10.1 ASSET PURCHASE AGREEMENT by and between NanoString Technologies, Inc., and Bruker Corporation Dated as of April 17, 2024 TABLE OF CONTENTS Page Article 1 DEFINITIONS............................................................................................................................... 1 1.1 Certain Defined Terms...................................................................

March 22, 2024 EX-99.1

31466467.1 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE In re: NANOSTRING TECHNOLOGIES, INC., et al.,1 Debtors. Chapter 11 Case No. 24-10160 (CTG) (Jointly Administered) GLOBAL NOTES TO MONTHLY OPERATING REPORT FOR NANOSTRING TE

31466467.1 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE In re: NANOSTRING TECHNOLOGIES, INC., et al.,1 Debtors. Chapter 11 Case No. 24-10160 (CTG) (Jointly Administered) GLOBAL NOTES TO MONTHLY OPERATING REPORT FOR NANOSTRING TECHNOLOGIES, INC. AND ITS DEBTOR AFFILIATES On February 4, 2024, NanoString Technologies, Inc. and its debtor affiliates, as debtors and debtors in pos

March 22, 2024 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 21, 2024 NanoString Technologies, Inc.

March 15, 2024 NT 10-K

UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ý Form 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨ Form N-CEN ¨ Form N-CSR For Period Ended: December 31, 2023 ☐Transition Report on Form 10-K ☐Transition Report on Form 20-F ☐Transition Report on Form 11-K ☐Transition Report on Form 10-Q For the Tra

March 12, 2024 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 10, 2024 NanoString Technolog

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 10, 2024 NanoString Technologies, Inc.

March 12, 2024 EX-99.1

Patient Square Capital, a Leading Health Care-Focused Investment Firm, Agrees to Acquire NanoString Technologies Binding Agreement to Acquire Substantially All NanoString Assets for $220 Million Pending Bankruptcy Court Approval Agreement Represents

Exhibit 99.1 Patient Square Capital, a Leading Health Care-Focused Investment Firm, Agrees to Acquire NanoString Technologies Binding Agreement to Acquire Substantially All NanoString Assets for $220 Million Pending Bankruptcy Court Approval Agreement Represents Major Step in Financial Restructuring and Provides Continuity for Customers and Employees Seattle, March 10, 2024 – (BUSINESS WIRE) - Nan

March 12, 2024 EX-10.1

ASSET PURCHASE AGREEMENT by and among NanoString Technologies, Inc., Nucleus Buyer, LLC Dated as of March10, 2024 TABLE OF CONTENTS

Exhibit 10.1 ASSET PURCHASE AGREEMENT by and among NanoString Technologies, Inc., and Nucleus Buyer, LLC Dated as of March10, 2024 TABLE OF CONTENTS Page Article 1 DEFINITIONS..................................................................................................................... 2 1.1 Certain Defined Terms......................................................................….........

February 14, 2024 SC 13G/A

NSTG / NanoString Technologies, Inc. / RA CAPITAL MANAGEMENT, L.P. - SC 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* NANOSTRING TECHNOLOGIES, INC. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 63009R109 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to design

February 14, 2024 EX-99.1

AGREEMENT

EXHIBIT 1 AGREEMENT This Joint Filing Agreement, dated as of February 14, 2024, is by and among RA Capital Management, L.

February 13, 2024 SC 13G/A

NSTG / NanoString Technologies, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SC 13G/A 1 tv01506-nanostringtechnologi.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 4)* Name of issuer: NanoString Technologies Inc Title of Class of Securities: Common Stock CUSIP Number: 63009R109 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate bo

February 13, 2024 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 13, 2024 NanoString Techno

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 13, 2024 NanoString Technologies, Inc.

February 13, 2024 SC 13G/A

NSTG / NanoString Technologies, Inc. / Prosight Management, LP - SC 13G/A Passive Investment

SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* NANOSTRING TECHNOLOGIES, INC. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 63009R109 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box

February 13, 2024 SC 13G/A

NSTG / NanoString Technologies, Inc. / Avidity Partners Management LP Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.

February 13, 2024 SC 13G/A

NSTG / NanoString Technologies, Inc. / Polar Capital Holdings Plc Passive Investment

SC 13G/A 1 polar-nstg123123a2.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* Nanostring Technologies, Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 63009R109 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) C

February 13, 2024 EX-10.1

Case No.

Information to identify the case: Debtor: NanoString Technologies, Inc. EIN: 20-0094687 United State Bankruptcy Court for the District of Delaware Case Number: 24-10160 (CTG) Date case filed in chapter 11: February 4, 2024 Official Form 309F1 (For Corporations or Partnerships) Notice of Chapter 11 Bankruptcy Case 10/20 For the debtor listed above, a case has been filed under chapter 11 of the Bank

February 8, 2024 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 05, 2024 NanoString Techno

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 05, 2024 NanoString Technologies, Inc.

February 8, 2024 EX-10.1

CREDIT AGREEMENT AND GUARANTY dated as of February 8, 2024 by and among NANOSTRING TECHNOLOGIES, INC., as the Borrower, THE GUARANTORS FROM TIME TO TIME PARTY HERETO, as the Guarantors, THE LENDERS FROM TIME TO TIME PARTIES HERETO, as the Lenders, WI

Exhibit 10.1 Execution Version CREDIT AGREEMENT AND GUARANTY dated as of February 8, 2024 by and among NANOSTRING TECHNOLOGIES, INC., as the Borrower, THE GUARANTORS FROM TIME TO TIME PARTY HERETO, as the Guarantors, THE LENDERS FROM TIME TO TIME PARTIES HERETO, as the Lenders, and WILMINGTON TRUST, NATIONAL ASSOCIATION, as the Agent U.S. $142,500,000 TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS 2

February 5, 2024 EX-99

NANOSTRING TAKES STEPS TO RESTRUCTURE ITS BUSINESS AND PROTECT ITS MISSION TO MAP THE UNIVERSE OF BIOLOGY Initiates Voluntary Chapter 11 Restructuring Proceedings with Additional $40 Million in Financing Secured from Existing Noteholders to Facilitat

Exhibit 99.1 NANOSTRING TAKES STEPS TO RESTRUCTURE ITS BUSINESS AND PROTECT ITS MISSION TO MAP THE UNIVERSE OF BIOLOGY Initiates Voluntary Chapter 11 Restructuring Proceedings with Additional $40 Million in Financing Secured from Existing Noteholders to Facilitate Process Continuing to Serve Life Sciences Researchers Worldwide Seattle, February 4, 2024 – (BUSINESS WIRE) - NanoString Technologies,

February 5, 2024 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 04, 2024 NanoString Techno

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 04, 2024 NanoString Technologies, Inc.

January 25, 2024 EX-10.1

NANOSTRING TECHNOLOGIES, INC.

Form of Insider Retention Bonus Letter NANOSTRING TECHNOLOGIES, INC. January [●], 2024 [●] BY HAND Re: Retention Bonus Opportunity Dear [●]: To encourage you to continue employment with NanoString Technologies, Inc. (the “Company”), you are being provided an opportunity to earn a retention bonus subject to the terms and conditions described in this letter agreement (this “Agreement”), which will b

January 25, 2024 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 19, 2024 NanoString Technologies, Inc.

January 25, 2024 SC 13G/A

NSTG / NanoString Technologies, Inc. / Titanite Investment Management LP - SC 13G/A Passive Investment

SC 13G/A 1 tm244078-1sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* NanoString Technologies, Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 63009R109 (CUSIP Number) January 19, 2024 (Date of Event Which Requires Filing of this statem

January 5, 2024 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 31, 2023 NanoString Techno

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 31, 2023 NanoString Technologies, Inc.

December 11, 2023 CORRESP

December 11, 2023

December 11, 2023 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.

November 30, 2023 424B3

NanoString Technologies, Inc. 16,000,000 Shares Common Stock Offered by the Selling Stockholders

PROSPECTUS Filed Pursuant to Rule 424(b)(3) Registration No. 333-275689 NanoString Technologies, Inc. 16,000,000 Shares Common Stock Offered by the Selling Stockholders The selling stockholders identified herein may from time to time offer or sell up to 16,000,000 shares of our common stock, $0.0001 par value per share, issuable upon exercise of warrants to purchase our common stock issued by us t

November 28, 2023 CORRESP

November 28, 2023

November 28, 2023 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Daniel Crawford Re: NanoString Technologies, Inc. Registration Statement on Form S-3 File No. 333-275689 Acceleration Request Requested Date: November 30, 2023 Requested Time: 4 P.M. Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 under th

November 22, 2023 SC 13D/A

NSTG / Nanostring Technologies Inc / WYGOD MARTIN J - SC 13D/A Activist Investment

SC 13D/A 1 ef20015192sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* NANOSTRING TECHNOLOGIES, INC. (Name of Issuer) Common Stock par value $0.0001 (Title of Class of Securities) 63009R109 (CUSIP Number) Martin J. Wygod P.O. Box 7188 Rancho Santa Fe, California 92067 (201) 703-3419 (N

November 21, 2023 EX-FILING FEES

CALCULATION OF FILING FEE TABLES Form S-3 (Form Type) NanoString Technologies, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities

CALCULATION OF FILING FEE TABLES Form S-3 (Form Type) NanoString Technologies, Inc.

November 21, 2023 S-3

As filed with the Securities and Exchange Commission on November 21, 2023

As filed with the Securities and Exchange Commission on November 21, 2023 Registration No.

November 20, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 17, 2023 NanoString Techno

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 17, 2023 NanoString Technologies, Inc.

November 20, 2023 EX-99.1

NanoString Comments on Delaware District Court Verdict

Exhibit 99.1 NanoString Comments on Delaware District Court Verdict SEATTLE – November 19, 2023 - NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, commented on the November 17th verdict of a jury in the U.S. District Court for the District of Delaware finding that NanoString GeoMx® Digital Spatial Profiler products inf

November 7, 2023 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2023 NanoString Technologies, Inc.

November 7, 2023 EX-10.2

REGISTRATION RIGHTS AGREEMENT

Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of November 7, 2023, by and among NanoString Technologies, Inc., a Delaware corporation (the “Company”), and each of the Investors from time to time signatory hereto. WHEREAS: A. In accordance with the Exchange Agreement, dated as of November 6, 2023, by and among the Company, the investors from t

November 7, 2023 EX-4.1

NANOSTRING TECHNOLOGIES, INC., THE GUARANTORS PARTY HERETO FROM TIME TO TIME, U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee and Collateral Agent Dated as of November 7, 2023 6.95% Senior Secured Notes due 2026 TABLE OF CONTENTS

Exhibit 4.1 NANOSTRING TECHNOLOGIES, INC., THE GUARANTORS PARTY HERETO FROM TIME TO TIME, AND U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee and Collateral Agent INDENTURE Dated as of November 7, 2023 6.95% Senior Secured Notes due 2026 TABLE OF CONTENTS Article 1 Definitions 1 Section 1.01 Definitions 1 Section 1.02 Interpretation 29 Section 1.03 Accounting Terms and Principles; Basket

November 7, 2023 EX-4.3

WARRANT TO PURCHASE SHARES OF COMMON STOCK OF NANOSTRING TECHNOLOGIES, INC.

Exhibit 4.3 WARRANT TO PURCHASE SHARES OF COMMON STOCK OF NANOSTRING TECHNOLOGIES, INC. Original Issue Date: [, , 202] No. W-[] FOR VALUE RECEIVED, the undersigned, NanoString Technologies, Inc., a Delaware corporation (together with its successors and assigns, the “Company”), hereby certifies that [] or any transferee, assignee or other subsequent holder hereof (the “Holder”) is entitled to subsc

November 6, 2023 8-K

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2023 NanoString Technologies, Inc.

November 6, 2023 EX-4.1

Form of 6.95% Senior Secured Note Due 2026 (included in Exhibit 4.1).

Exhibit 4.1 NANOSTRING TECHNOLOGIES, INC., THE GUARANTORS PARTY HERETO FROM TIME TO TIME, AND U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee and Collateral Agent INDENTURE Dated as of November [], 2023 6.95% Senior Secured Notes due 2026 TABLE OF CONTENTS Article 1 Definitions 1 Section 1.01 Definitions 1 Section 1.02 Interpretation 29 Section 1.03 Accounting Terms and Principles; Baske

November 6, 2023 EX-99.1

NanoString Technologies Releases Operating Results for Third Quarter of 2023 Completed Exchange Transaction with Convertible Note Holders Representing 94% of Outstanding Principal – Record Q3 Revenue of $48.1 Million, 63% Year on Year Growth and Abov

Exhibit 99.1 NanoString Technologies Releases Operating Results for Third Quarter of 2023 Completed Exchange Transaction with Convertible Note Holders Representing 94% of Outstanding Principal – Record Q3 Revenue of $48.1 Million, 63% Year on Year Growth and Above Upper End of Q3 Guidance Range – SEATTLE - November 6, 2023 - NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life s

November 6, 2023 EX-10.2

, 2023, between the Registrant and John Gerace.

530 Fairview Avenue N Seattle, WA 98109 VIA EMAIL ([email protected]) August 3, 2023 Calabri Biosciences, LLC Attn: John Gerace 37 Barlett Place Tustin, CA 92782 Re: Consulting Services Dear John: This letter agreement (this “Agreement”) confirms our mutual understanding with respect to the terms and conditions upon which Calabri Biosciences, LLC (“Calabri”) agrees to provide NanoString Technologi

November 6, 2023 EX-10.3

, 2023, between the Registrant and Todd Garland.

NANOSTRING TECHNOLOGIES, INC. EMPLOYMENT AGREEMENT This Employment Agreement (the “Agreement”) is entered into, effective as of August 28, 2023 (the “Effective Date”), by and between NanoString Technologies, Inc. (the “Company”) and Jonathan Todd Garland (“Executive”). 1.Duties and Scope of Employment. (a)Positions and Duties. As of the Effective Date, Executive will serve as the Chief Commercial

November 6, 2023 EX-4.3

Form of Warrant

Exhibit 4.3 WARRANT TO PURCHASE SHARES OF COMMON STOCK OF NANOSTRING TECHNOLOGIES, INC. Original Issue Date: [, , 202] No. W-[] FOR VALUE RECEIVED, the undersigned, NanoString Technologies, Inc., a Delaware corporation (together with its successors and assigns, the “Company”), hereby certifies that [] or any transferee, assignee or other subsequent holder hereof (the “Holder”) is entitled to subsc

November 6, 2023 EX-10.1

, 2023, by and among the Company, NanoString Technologies International, Inc. and the Investors party thereto.

Exhibit 10.1 NanoString Technologies, Inc. November 6, 2023 1.Introduction. NanoString Technologies, Inc., a Delaware corporation (the “Company”), proposes to exchange (the “Exchange Transaction” or the “Transactions”) $215,724,000.00 aggregate principal amount of the Company’s 2.625% Convertible Senior Notes due 2025, CUSIP 63009R AD1 (the “Old Notes”) held by certain existing holders of the Old

November 6, 2023 EX-10.2

Form of Registration Rights Agreement

Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of November [], 2023, by and among NanoString Technologies, Inc., a Delaware corporation (the “Company”), and each of the Investors from time to time signatory hereto. WHEREAS: A. In accordance with the Exchange Agreement, dated as of November 6, 2023, by and among the Company, the investors from

November 6, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35980

October 10, 2023 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Costs Associated with Exit or Disposal Activities, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 6, 2023 NanoString Technologies, Inc.

October 10, 2023 EX-99.1

NanoString Provides Preliminary Financial and Operational Highlights for Third Quarter of 2023 - Record Q3 Revenue of Over $48 Million, 63% Year on Year Growth, Above Upper End of Q3 Guidance Range - - Implementing Reorganization of R&D and Manufactu

Exhibit 99.1 NanoString Provides Preliminary Financial and Operational Highlights for Third Quarter of 2023 - Record Q3 Revenue of Over $48 Million, 63% Year on Year Growth, Above Upper End of Q3 Guidance Range - - Implementing Reorganization of R&D and Manufacturing Operations to Improve Path to Profitability - SEATTLE - October 10, 2023 - NanoString Technologies, Inc. (NASDAQ:NSTG), a leading pr

October 5, 2023 SC 13D/A

NSTG / Nanostring Technologies Inc / WYGOD MARTIN J - SC 13D/A Activist Investment

SC 13D/A 1 ef20012011sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* NANOSTRING TECHNOLOGIES, INC. (Name of Issuer) Common Stock par value $0.0001 (Title of Class of Securities) 63009R109 (CUSIP Number) Martin J. Wygod P.O. Box 7188 Rancho Santa Fe, California 92067 (201) 703-3419 (N

September 28, 2023 SC 13D

NSTG / Nanostring Technologies Inc / WYGOD MARTIN J - SC 13D Activist Investment

SC 13D 1 ef20011451sc13d.htm SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.)* NANOSTRING TECHNOLOGIES, INC. (Name of Issuer) Common Stock par value $0.0001 (Title of Class of Securities) 63009R109 (CUSIP Number) Martin J. Wygod P.O. Box 7188 Rancho Santa Fe, California 92067 (201) 703-3419 (Name, Ad

September 12, 2023 EX-99.1

The image part with relationship ID rId2 was not found in the file. Morgan Stanley Global Healthcare Conference Baird Global Healthcare Conference September 12 and 13, 2023 This presentation and the accompanying oral commentary contain forward-lookin

exhibit991 The image part with relationship ID rId2 was not found in the file. Morgan Stanley Global Healthcare Conference Baird Global Healthcare Conference September 12 and 13, 2023 This presentation and the accompanying oral commentary contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and the

September 12, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 12, 2023 NanoString Techn

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 12, 2023 NanoString Technologies, Inc.

September 7, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 5, 2023 NanoString Techno

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 5, 2023 NanoString Technologies, Inc.

September 1, 2023 SC 13G

NSTG / Nanostring Technologies Inc / Prosight Management, LP - SC 13G Passive Investment

SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* NANOSTRING TECHNOLOGIES, INC. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 63009R109 (CUSIP Number) August 23, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box to de

September 1, 2023 EX-99.1

JOINT FILING AGREEMENT September 1, 2023

EX-99.1 2 d549620dex991.htm EX-99.1 Exhibit 99.1 JOINT FILING AGREEMENT September 1, 2023 Pursuant to and in accordance with the Securities Exchange Act of 1934, as amended (the “Act”), and the rules and regulations thereunder, each party hereto hereby agrees to the joint filing, on behalf of each of them, of any filing required by such party under Section 13 or Section 16 of the Act or any rule o

August 21, 2023 SC 13G

NSTG / Nanostring Technologies Inc / Titanite Investment Management LP - SC 13G Passive Investment

SC 13G 1 tm2324295d1sc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* NanoString Technologies, Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 63009R109 (CUSIP Number) August 16, 2023 (Date of Event Which Requires Filing of this statement) C

August 21, 2023 EX-99.1

Joint Filing Agreement

EX-99.1 2 tm2324295d1ex1.htm EXHIBIT 1 Exhibit 1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock, $0.0001 par value per share, of NanoString Technologies, Inc., and f

August 3, 2023 EX-FILING FEES

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) NanoString Technologies, Inc.

August 3, 2023 8-K

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2023 NanoString Technologies, Inc.

August 3, 2023 EX-99.1

NanoString Technologies Releases Operating Results for Second Quarter of 2023 – Record Q2 Revenue of $44.2 Million, 37% Year on Year Growth and Above Upper End of Q2 Guidance Range – - Retained More than $35 Million in CosMx Instrument Order Backlog

Exhibit 99.1 NanoString Technologies Releases Operating Results for Second Quarter of 2023 – Record Q2 Revenue of $44.2 Million, 37% Year on Year Growth and Above Upper End of Q2 Guidance Range – - Retained More than $35 Million in CosMx Instrument Order Backlog at the End of Q2 - SEATTLE - August 3, 2023 - NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for d

August 3, 2023 EX-10.1

2018 Inducement Equity Incentive Plan, as amended.

AMENDED AND RESTATED 2018 INDUCEMENT EQUITY INCENTIVE PLAN NANOSTRING TECHNOLOGIES, INC.

August 3, 2023 S-8

As filed with the Securities and Exchange Commission on August 3, 2023 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT The Securities Act of 1933 NANOSTRING TECHNOLOGIES, I

As filed with the Securities and Exchange Commission on August 3, 2023 Registration No.

August 3, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35980 NANO

July 13, 2023 SC 13G/A

NSTG / Nanostring Technologies Inc / Polar Capital Holdings Plc Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No.

July 10, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 10, 2023 NanoString Technologi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 10, 2023 NanoString Technologies, Inc.

July 10, 2023 EX-99.1

NanoString Provides Preliminary Financial and Operational Highlights for Second Quarter of 2023 - Record Q2 Revenue of Over $44 Million, 37% Year on Year Growth and Above Upper End of Q2 Guidance Range - - New Orders for CosMx Instruments Grew Sequen

Exhibit 99.1 NanoString Provides Preliminary Financial and Operational Highlights for Second Quarter of 2023 - Record Q2 Revenue of Over $44 Million, 37% Year on Year Growth and Above Upper End of Q2 Guidance Range - - New Orders for CosMx Instruments Grew Sequentially and Year on Year - SEATTLE - July 10, 2023 - NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools

June 27, 2023 EX-10.1

Amended and Restated 2022 Equity Incentive Plan.

AMENDED AND RESTATED 2022 EQUITY INCENTIVE PLAN NANOSTRING TECHNOLOGIES, INC. 2022 EQUITY INCENTIVE PLAN 1.Purposes of the Plan. The purposes of this Plan are: •to attract and retain the best available personnel for positions of substantial responsibility, •to provide additional incentive to Employees, Directors and Consultants, and •to promote the success of the Company’s business. The Plan permi

June 27, 2023 EX-10.2

2018 Inducement Equity Incentive Plan, as amended.

AMENDED AND RESTATED 2018 INDUCEMENT EQUITY INCENTIVE PLAN NANOSTRING TECHNOLOGIES, INC.

June 27, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 23, 2023 NanoString Technologi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 23, 2023 NanoString Technologies, Inc.

June 27, 2023 EX-FILING FEES

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) NanoString Technologies, Inc.

June 27, 2023 S-8

As filed with the Securities and Exchange Commission on June 27, 2023 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT The Securities Act of 1933 NANOSTRING TECHNOLOGIES, IN

As filed with the Securities and Exchange Commission on June 27, 2023 Registration No.

June 27, 2023 EX-3.1

Amended and Restated Certificate of Incorporation of the Registrant.

NanoString Technologies, Inc. AMENDED AND RESTATED CERTIFICATE OF INCORPORATION NanoString Technologies, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), hereby certifies as follows: A. The original Certificate of Incorporation of this Corporation was originally filed with the Secretary of State of Delaware on June 20, 2003. B. This Amended an

June 9, 2023 SC 13G/A

NSTG / Nanostring Technologies Inc / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5 )* NanoString Technologies Inc (Name of Issuer) Common Stock (Title of Class of Securities) 63009R109 (CUSIP Number) May 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this

May 31, 2023 EX-1.01

Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form.

Exhibit 1.01 NANOSTRING TECHNOLOGIES, INC. Conflict Minerals Report For the Year Ended December 31, 2022 This report for the year ended December 31, 2022 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934, as modified by SEC guidance issued on April 29, 2014 and the SEC order issued on May 2, 2014 (the “Rule”). The Rule was adopted by the Securities and Exchange Commi

May 31, 2023 SD

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report NanoString Technologies, Inc. (Exact name of registrant as specified in its charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report NanoString Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35980 20-0094687 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 530 Fairview Avenue North Seattle, Washington 98109 (Address of princ

May 25, 2023 SC 13G

NSTG / Nanostring Technologies Inc / Avidity Partners Management LP Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.

May 3, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2023 NanoString Technologies

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2023 NanoString Technologies, Inc.

May 3, 2023 EX-99.1

NanoString Technologies Releases Operating Results for First Quarter of 2023 – Q1 Revenue of $35.8 Million – - Total Spatial Biology and nCounter Revenue Above Upper End of Q1 Guidance Ranges - - Raising Annual Revenue Guidance to $175-185 Million -

Exhibit 99.1 NanoString Technologies Releases Operating Results for First Quarter of 2023 – Q1 Revenue of $35.8 Million – - Total Spatial Biology and nCounter Revenue Above Upper End of Q1 Guidance Ranges - - Raising Annual Revenue Guidance to $175-185 Million - SEATTLE - May 3, 2023 - NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translati

May 3, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File: Number 001-35980 NA

April 28, 2023 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ý Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ý Definitive Proxy State

April 28, 2023 ARS

ARS

nstg-2023ars

April 28, 2023 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ý Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy State

April 14, 2023 PRE 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ý Filed by a party other than the Registrant ¨ Check the appropriate box: ý Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy State

April 10, 2023 SC 13G

NSTG / Nanostring Technologies Inc / RA CAPITAL MANAGEMENT, L.P. - SC 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* NANOSTRING TECHNOLOGIES, INC. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 63009R109 (CUSIP Number) March 30, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate

March 2, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2023 NanoString Techno

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2023 NanoString Technologies, Inc.

February 28, 2023 S-8

As filed with the Securities and Exchange Commission on February 28, 2023 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT The Securities Act of 1933 NANOSTRING TECHNOLOGIES

As filed with the Securities and Exchange Commission on February 28, 2023 Registration No.

February 28, 2023 EX-FILING FEES

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) NanoString Technologies, Inc.

February 28, 2023 EX-10.9

Form of RSU Agreement under the 2018 Inducement Equity Incentive Plan.

EXHIBIT 10.9 NANOSTRING TECHNOLOGIES, INC. 2018 INDUCEMENT EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT AGREEMENT Unless otherwise defined herein, the terms defined in the NanoString Technologies, Inc. 2018 Inducement Equity Incentive Plan (the “Plan”) will have the same defined meanings in this Restricted Stock Unit Agreement (the “Award Agreement”), which includes the Notice of Restricted Stock U

February 28, 2023 EX-10.8

2018 Inducement Equity Incentive Plan

EXHIBIT 10.8 NANOSTRING TECHNOLOGIES, INC. 2018 INDUCEMENT EQUITY INCENTIVE PLAN 1.Purposes of the Plan. The purposes of this Plan are to attract and retain the best available personnel for positions of substantial responsibility by providing an inducement material to individuals entering into employment with the Company or any Parent or Subsidiary of the Company. The Plan permits the grant of Non

February 28, 2023 EX-10.10

Form of Stock Option Agreement under the 2018 Inducement Equity Incentive Plan.

EXHIBIT 10.10 NANOSTRING TECHNOLOGIES, INC. 2018 INDUCEMENT EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT Unless otherwise defined herein, the terms defined in the NanoString Technologies, Inc. 2018 Inducement Equity Incentive Plan (the “Plan”) will have the same defined meanings in this Stock Option Agreement (the “Agreement”), including the Notice of Stock Option Grant (the “Notice of Grant”) and

February 28, 2023 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ¨ TRANSITION REPORT PURSUANT TO SECTI

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 Or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35980 NANOSTR

February 28, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2023 NanoString Techno

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2023 NanoString Technologies, Inc.

February 28, 2023 EX-99.1

NanoString Technologies Releases Fourth Quarter and Full Year 2022 Operating Results and Provides 2023 Financial Outlook - Generated Record Orders for Over 105 Spatial Biology Instruments, Representing 50% Growth Year-over-Year - - Q4 Revenue Over $3

Exhibit 99.1 NanoString Technologies Releases Fourth Quarter and Full Year 2022 Operating Results and Provides 2023 Financial Outlook - Generated Record Orders for Over 105 Spatial Biology Instruments, Representing 50% Growth Year-over-Year - - Q4 Revenue Over $34 Million - SEATTLE - February 28, 2023 - NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for disco

February 28, 2023 EX-4.3

Description of Capital Stock.

Exhibit 4.3 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of December 31, 2022, NanoString Technologies, Inc. (the “Company”) had one class of securities, our common stock, registered under Section 12 of the Securities Exchange Act of 1934, as amended. These securities are listed on the Nasdaq Global Market under the symbol “

February 14, 2023 SC 13G/A

NSTG / NanoString Technologies Inc / RA CAPITAL MANAGEMENT, L.P. - SC 13G/A Passive Investment

SC 13G/A 1 tm236221d12sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* NANOSTRING TECHNOLOGIES, INC. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 63009R109 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this St

February 14, 2023 SC 13G

NSTG / NanoString Technologies Inc / Polar Capital Holdings Plc Passive Investment

SC 13G 1 polar-nstg123122.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Nanostring Technologies, Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 63009R109 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check th

February 9, 2023 SC 13G/A

NSTG / NanoString Technologies Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 3)* Name of issuer: NanoString Technologies Inc. Title of Class of Securities: Common Stock CUSIP Number: 63009R109 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pursuant to which this Schedule is

February 6, 2023 SC 13G/A

NSTG / NanoString Technologies Inc / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4 )* NanoString Technologies Inc (Name of Issuer) Common Stock (Title of Class of Securities) 63009R109 (CUSIP Number) December 30, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which

January 27, 2023 EX-3.1

Amended and Restated Bylaws of the Registrant.

EX-3.1 2 exhibit31.htm EX-3.1 Exhibit 3.1 AMENDED AND RESTATED BYLAWS OF NANOSTRING TECHNOLOGIES, INC. (as amended and restated on January 25, 2023) TABLE OF CONTENTS Page ARTICLE I — CORPORATE OFFICES 1 1.1 REGISTERED OFFICE 1 1.2 OTHER OFFICES 1 ARTICLE II — MEETINGS OF STOCKHOLDERS 1 2.1 PLACE OF MEETINGS 1 2.2 ANNUAL MEETING 1 2.3 SPECIAL MEETING 1 2.4 ADVANCE NOTICE PROCEDURES 1 2.5 NOTICE OF

January 27, 2023 8-K

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 25, 2023 NanoString Technologies, Inc.

January 9, 2023 EX-99.1

NanoString Provides Preliminary Financial and Operational Highlights for Fourth Quarter and FY 2022 Generated Record Orders for Over 105 Spatial Biology Instruments in Q4, Representing 50% Growth Year-over-Year Q4 Product and Service Revenue of Over

EX-99.1 2 nstg-2022ex991revenuesjpmo.htm EX-99.1 Exhibit 99.1 NanoString Provides Preliminary Financial and Operational Highlights for Fourth Quarter and FY 2022 Generated Record Orders for Over 105 Spatial Biology Instruments in Q4, Representing 50% Growth Year-over-Year Q4 Product and Service Revenue of Over $34 Million, Within Guidance Range of $33 to $35 Million SEATTLE - January 8, 2023 - Nan

January 9, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 8, 2023 NanoString Technolo

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 8, 2023 NanoString Technologies, Inc.

December 12, 2022 SC 13G/A

NSTG / NanoString Technologies Inc / ALGER ASSOCIATES INC - NANOSTRING TECHNOLOGIES, INC. Passive Investment

NanoString Technologies, Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* NanoString Technologies, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 63009R109 (CUSIP Number) November 30, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to desig

November 7, 2022 EX-99.1

NanoString Technologies Releases Operating Results for Third Quarter of 2022 Generated Orders for ~60 Spatial Biology Instruments, Representing ~70% Growth Year-over-Year, Including Orders for ~40 CosMx Spatial Molecular Imagers

Exhibit 99.1 NanoString Technologies Releases Operating Results for Third Quarter of 2022 Generated Orders for ~60 Spatial Biology Instruments, Representing ~70% Growth Year-over-Year, Including Orders for ~40 CosMx Spatial Molecular Imagers SEATTLE - November 7, 2022 - NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, t

November 7, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File: Number 001-3598

November 7, 2022 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Costs Associated with Exit or Disposal Activities, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2022 NanoString Technologies, Inc.

August 4, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File: Number 001-35980 NAN

August 4, 2022 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 4, 2022 NanoString Technologies, Inc.

August 4, 2022 EX-99.1

NanoString Technologies Releases Operating Results for Second Quarter of 2022 Generated Orders for ~ 50 Spatial Biology Instruments, Representing 65% Growth Year-over-Year, Including Orders for More than 25 CosMx Spatial Molecular Imagers

Exhibit 99.1 NanoString Technologies Releases Operating Results for Second Quarter of 2022 Generated Orders for ~ 50 Spatial Biology Instruments, Representing 65% Growth Year-over-Year, Including Orders for More than 25 CosMx Spatial Molecular Imagers SEATTLE - August 4, 2022 - NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational res

June 21, 2022 S-8 POS

As filed with the Securities and Exchange Commission on June 17, 2022

As filed with the Securities and Exchange Commission on June 17, 2022 Registration No.

June 17, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 17, 2022 NanoString Technologies, Inc.

June 17, 2022 EX-10.3

Form of Restricted Stock Unit Agreement under the 2022 Equity Incentive Plan

Exhibit 10.3 NANOSTRING TECHNOLOGIES, INC. 2022 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT AGREEMENT Unless otherwise defined herein, the terms defined in the NanoString Technologies, Inc. 2022 Equity Incentive Plan (the ?Plan?) will have the same defined meanings in this Restricted Stock Unit Agreement (the ?Award Agreement?), which includes the Notice of Restricted Stock Unit Grant (the ?Notice

June 17, 2022 S-8

Power of Attorney (contained on signature page hereto).

As filed with the Securities and Exchange Commission on June 17, 2022 Registration No.

June 17, 2022 EX-10.2

Form of Stock Option Agreement under the 2022 Equity Incentive Plan

Exhibit 10.2 NANOSTRING TECHNOLOGIES, INC. 2022 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT Unless otherwise defined herein, the terms defined in the NanoString Technologies, Inc. 2022 Equity Incentive Plan (the ?Plan?) will have the same defined meanings in this Stock Option Agreement (the ?Agreement?), including the Notice of Stock Option Grant (the ?Notice of Grant?) and Terms and Conditions o

June 17, 2022 EX-10.4

Form of Performance-Based Restricted Stock Unit Agreement under the 2022 Equity Incentive Plan

Exhibit 10.4 NANOSTRING TECHNOLOGIES, INC. 2022 EQUITY INCENTIVE PLAN PERFORMANCE-BASED RESTRICTED STOCK UNIT AGREEMENT Unless otherwise defined herein, the terms defined in the NanoString Technologies, Inc. 2022 Equity Incentive Plan (the ?Plan?) will have the same defined meanings in this Performance-Based Restricted Stock Unit Agreement (the ?Award Agreement?), which includes the Notice of Perf

June 17, 2022 EX-10.1

2022 Equity Incentive Plan

Exhibit 10.1 NANOSTRING TECHNOLOGIES, INC. 2022 EQUITY INCENTIVE PLAN 1.Purposes of the Plan. The purposes of this Plan are: ?to attract and retain the best available personnel for positions of substantial responsibility, ?to provide additional incentive to Employees, Directors and Consultants, and ?to promote the success of the Company?s business. The Plan permits the grant of Incentive Stock Opt

June 17, 2022 EX-FILING FEES

Filing Fee Table.

Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) NanoString Technologies, Inc.

May 27, 2022 EX-1.01

Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form.

Exhibit 1.01 NANOSTRING TECHNOLOGIES, INC. Conflict Minerals Report For the Year Ended December 31, 2021 This report for the year ended December 31, 2021 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934, as modified by SEC guidance issued on April 29, 2014 and the SEC order issued on May 2, 2014 (the ?Rule?). The Rule was adopted by the Securities and Exchange Commi

May 27, 2022 SD

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report NanoString Technologies, Inc. (Exact name of registrant as specified in its charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report NanoString Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35980 20-0094687 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 530 Fairview Avenue North Seattle, Washington 98109 (Address of princ

May 10, 2022 EX-10.3

Exclusive License Agreement, dated February 4, 2004, between the Registrant and The Institute for Systems Biology.

Exhibit 10.3 CERTAIN INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. OMISSIONS ARE DESIGNATED AS [?]. EXCLUSIVE LICENSE AGREEMENT Between NanoString Technologies, Inc. (Licensee) And The Institute for Systems Biology (INSTITUTE) This Exclusive License Agreement (hereinafter called ?Agre

May 10, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File: Number 001-35980 NA

May 10, 2022 EX-10.4

Amendment No. 1 to Exclusive License Agreement, dated February 5, 2007, between the Registrant and The Institute for Systems Biology.

Exhibit 10.4 CERTAIN INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. OMISSIONS ARE DESIGNATED AS [?]. AMENDMENT NO. 1 TO EXCLUSIVE LICENSE AGREEMENT This Amendment No. 1 to Exclusive License Agreement ("Amendment") is entered into on February 5, 2007, by and between the Institute for Sy

May 10, 2022 EX-99.1

NanoString Technologies Releases Operating Results for First Quarter of 2022

Exhibit 99.1 NanoString Technologies Releases Operating Results for First Quarter of 2022 SEATTLE - May 10, 2022 - NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the first quarter ended March 31, 2022. First Quarter Financial Highlights ?Product and service revenue of $30.8 million

May 10, 2022 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2022 NanoString Technologies, Inc.

April 29, 2022 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State

April 29, 2022 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State

April 29, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 26, 2022 NanoString Technologies, Inc.

April 28, 2022 SC 13G

NSTG / NanoString Technologies Inc / RA CAPITAL MANAGEMENT, L.P. - NANOSTRING TECHNOLOGIES INC Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* NANOSTRING TECHNOLOGIES, INC. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 63009R109 (CUSIP Number) April 18, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate

April 18, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 13, 2022 NanoString Technologies, Inc.

April 18, 2022 EX-99.1

NanoString Appoints Dr. Teresa Foy to Board of Directors Dr. Rob Hershberg steps down from Board after 7 years of service

EX-99.1 2 nstg8kex99104182022.htm EX-99.1 Exhibit 99.1 NanoString Appoints Dr. Teresa Foy to Board of Directors Dr. Rob Hershberg steps down from Board after 7 years of service SEATTLE, Wash., April 18, 2022/Business Wire/- NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the appointment of Dr. Teresa (

April 12, 2022 EX-99.1

NanoString Technologies Announces Preliminary Revenue for First Quarter of Fiscal Year 2022

Exhibit 99.1 NanoString Technologies Announces Preliminary Revenue for First Quarter of Fiscal Year 2022 SEATTLE - April 12, 2022 - NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced preliminary total product and service revenue of approximately $31 million for the first quarter. This unaudited estimate, b

April 12, 2022 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 12, 2022 NanoString Technologies, Inc.

March 1, 2022 EX-21.1

List of subsidiaries of the Registrant.

Exhibit 21.1 SUBSIDIARIES OF NANOSTRING TECHNOLOGIES, INC. Name of Subsidiary State or other Jurisdiction of Incorporation NanoString Technologies Europe Limited United Kingdom NanoString Technologies SAS France NanoString Technologies International, Inc. Delaware NanoString Technologies Germany GmbH Germany NanoString Technologies Asia Pacific Limited Hong Kong NanoString Technologies Singapore P

March 1, 2022 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 1, 2022 NanoString Technologies, Inc.

March 1, 2022 EX-10.24

Employment Agreement dated January 6, 2022, between the Registrant and John Gerace.

Exhibit 10.24 NANOSTRING TECHNOLOGIES, INC. EMPLOYMENT AGREEMENT This Employment Agreement (the ?Agreement?) is entered into, effective as of January 6, 2022 (the ?Effective Date?), by and between NanoString Technologies, Inc. (the ?Company?) and John D. Gerace (?Executive?). 1.Duties and Scope of Employment. (a)Positions and Duties. As of the Effective Date, Executive will serve as the Chief Comm

March 1, 2022 EX-FILING FEES

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) NanoString Technologies, Inc.

March 1, 2022 EX-10.21

Transition Agreement and Release dated January 7, 2022, between the Registrant and J. Chad Brown.

Exhibit 10.21 TRANSITION AGREEMENT AND RELEASE This Transition Agreement and Release (?Agreement?) is made by and between J. Chad Brown (?Employee?) and NanoString Technologies, Inc. (the ?Company?) (collectively referred to as the ?Parties? or individually referred to as a ?Party?). WHEREAS, Employee was employed at-will by the Company pursuant to that certain Employment Agreement between the Par

March 1, 2022 S-8

As filed with the Securities and Exchange Commission on March 1, 2022 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT The Securities Act of 1933 NANOSTRING TECHNOLOGIES, IN

As filed with the Securities and Exchange Commission on March 1, 2022 Registration No.

March 1, 2022 EX-10.31

Amendment No. 3 to Office Lease Agreement between the Registrant and Blume Roy Building LLC, dated July 20, 2021.

EX-10.31 4 nstg-2021ex1031.htm EX-10.31 AMENDMENT NO. 3 TO OFFICE LEASE AGREEMENT THIS AMENDMENT NO. 3 TO THE OFFICE LEASE AGREEMENT (“Third Amendment”) is made and entered into effective as of July 20, 2021 (“Effective Date”), by and between BLUME ROY BUILDING LLC, a Washington Limited Liability Company, ("Landlord") and NANOSTRING TECHNOLOGIES, INC., a Delaware corporation ("Tenant"). RECITALS A

March 1, 2022 EX-99.1

NanoString Technologies Releases Fourth Quarter and Full Year 2021 Operating Results and Provides 2022 Financial Outlook

Exhibit 99.1 NanoString Technologies Releases Fourth Quarter and Full Year 2021 Operating Results and Provides 2022 Financial Outlook SEATTLE - March 1, 2022 - NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the fourth quarter and year ended December 31, 2021. Fourth Quarter Financi

March 1, 2022 S-8 POS

As filed with the Securities and Exchange Commission on March 1, 2022

As filed with the Securities and Exchange Commission on March 1, 2022 Registration No.

March 1, 2022 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTI

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 Or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35980 NANOSTR

February 22, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 15, 2022 NanoString Technologies, Inc.

February 14, 2022 SC 13G/A

NSTG / NanoString Technologies Inc / ALGER ASSOCIATES INC - NANOSTRING TECHNOLOGIES, INC. Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* NanoString Technologies, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 63009R109 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whic

February 10, 2022 SC 13G/A

NSTG / NanoString Technologies Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2)* Name of issuer: NanoString Technologies Inc. Title of Class of Securities: Common Stock CUSIP Number: 63009R109 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is

February 4, 2022 SC 13G/A

NSTG / NanoString Technologies Inc / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3 )* NanoString Technologies Inc (Name of Issuer) Common Stock (Title of Class of Securities) 63009R109 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which

January 10, 2022 EX-99.1

NanoString Provides Preliminary Financial and Operational Highlights for Fourth Quarter and FY 2021 - Record Q4 Product and Service Revenue of $42 Million, Including GeoMx Revenue of $18 Million -

Exhibit 99.1 NanoString Provides Preliminary Financial and Operational Highlights for Fourth Quarter and FY 2021 - Record Q4 Product and Service Revenue of $42 Million, Including GeoMx Revenue of $18 Million - SEATTLE - January 9, 2022 - NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported preliminary financi

January 10, 2022 8-K

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 5, 2022 NanoString Technologies, Inc.

January 10, 2022 EX-99.2

NanoString Announces Transition in Commercial Leadership Chad Brown to Retire Following More than Four Successful Years as SVP, Sales & Marketing Genomics and Diagnostics Veteran John D. Gerace Appointed as Chief Commercial Officer

Exhibit 99.2 NanoString Announces Transition in Commercial Leadership Chad Brown to Retire Following More than Four Successful Years as SVP, Sales & Marketing Genomics and Diagnostics Veteran John D. Gerace Appointed as Chief Commercial Officer SEATTLE ? January 9, 2022 ? NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research,

November 10, 2021 SC 13G/A

NSTG / NanoString Technologies Inc / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* NanoString Technologies Inc (Name of Issuer) Common Stock (Title of Class of Securities) 63009R109 (CUSIP Number) October 29, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which

November 9, 2021 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2021 NanoString Technologies, Inc.

November 9, 2021 EX-99.1

NanoString Releases Operating Results for Third Quarter of 2021

EX-99.1 2 nstg-20218kex991.htm EX-99.1 Exhibit 99.1 NanoString Releases Operating Results for Third Quarter of 2021 SEATTLE - November 9, 2021 - NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the third quarter ended September 30, 2021. Third Quarter Financial Highlights •Product an

November 9, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File: Number 001-3598

August 5, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File: Number 001-35980 NAN

August 4, 2021 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 4, 2021 NanoString Technologies, Inc.

August 4, 2021 EX-99.1

NanoString Releases Operating Results for Second Quarter of 2021

Exhibit 99.1 NanoString Releases Operating Results for Second Quarter of 2021 SEATTLE - August 4, 2021 - NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the second quarter ended June 30, 2021. Second Quarter Financial Highlights ?Product and service revenue of $33.6 million, 59% yea

June 21, 2021 8-K

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 16, 2021 NanoString Technologies, Inc.

May 27, 2021 SD

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM SD Specialized Disclosure Report NanoString Technologies, Inc. (Exact name of registrant as specified in its charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM SD Specialized Disclosure Report NanoString Technologies, Inc.

May 27, 2021 EX-1.01

Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form.

EX-1.01 2 nstgex101.htm EX-1.01 Exhibit 1.01 NANOSTRING TECHNOLOGIES, INC. Conflict Minerals Report For the Year Ended December 31, 2020 This report for the year ended December 31, 2020 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934, as modified by SEC guidance issued on April 29, 2014 and the SEC order issued on May 2, 2014 (the “Rule”). The Rule was adopted by t

May 10, 2021 10-Q

Quarterly Report - 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File: Number 001-35980 NA

May 10, 2021 EX-99.1

NanoString Technologies Releases Operating Results for First Quarter of 2021

Exhibit 99.1 NanoString Technologies Releases Operating Results for First Quarter of 2021 SEATTLE - May 10, 2021 - NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the first quarter ended March 31, 2021. First Quarter Financial Highlights ?Product and service revenue of $31.4 million

May 10, 2021 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2021 NanoString Technologies, Inc.

April 28, 2021 DEF 14A

- DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)

April 28, 2021 DEFA14A

- DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)

March 9, 2021 EX-99.1

NanoString Appoints Dr. Dana Rollison and Janet George to Board of Directors

Exhibit 99.1 NanoString Appoints Dr. Dana Rollison and Janet George to Board of Directors SEATTLE, Wash., March 9, 2021/Business Wire/- NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the appointment of two new board members, Dr. Dana Rollison and Janet George, effective March 8, 2021. “I’m thrilled to

March 9, 2021 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 8, 2021 NanoString Technologies, Inc.

March 2, 2021 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2021 NanoString Technologies, Inc.

March 1, 2021 10-K

Annual Report - 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 Or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35980 NANOSTR

March 1, 2021 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 1, 2021 NanoString Technologies, Inc.

March 1, 2021 S-8

Power of Attorney (contained on signature page hereto).

As filed with the Securities and Exchange Commission on March 1, 2021 Registration No.

March 1, 2021 EX-99.1

NanoString Technologies Releases Fourth Quarter and Full Year 2020 Operating Results and Provides 2021 Financial Outlook

Exhibit 99.1 NanoString Technologies Releases Fourth Quarter and Full Year 2020 Operating Results and Provides 2021 Financial Outlook SEATTLE - March 1, 2021 - NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the fourth quarter and year ended December 31, 2020. Fourth Quarter Financi

February 17, 2021 SC 13G/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* NanoString Technologies, Inc. (Name of Issuer) Common Stock, $0.0001 Par Value (Title of Class of Securiti

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.

February 17, 2021 EX-1

Joint Filing Statement Statement Pursuant to Rule 13d-1(k)(1)

EX-1 2 ex1.htm Exhibit 1 Joint Filing Statement Statement Pursuant to Rule 13d-1(k)(1) The undersigned hereby consent and agree to file a joint statement on Schedule 13G under the Securities Exchange Act of 1934, as amended, with respect to the Common Stock, $0.0001 Par Value, of NanoString Technologies, Inc., beneficially owned by them, together with any or all amendments thereto, when and if app

February 16, 2021 SC 13G/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 3)* NanoString Technologies Inc. (Name of Issuer) Common Stock (Title of Class of Securities) (CUSIP Number) D

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.

February 16, 2021 SC 13G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Nanostring Technologies, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) (CUSIP Number)

Nanostring Technologies, Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Nanostring Technologies, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 63009R109 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to design

February 12, 2021 SC 13G/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 6)*

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.

February 11, 2021 SC 13G/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* NanoString Technologies, Inc.

SC 13G/A 1 brhc10020182sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* NanoString Technologies, Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 63009R109 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Sta

February 10, 2021 SC 13G/A

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1)*

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1)* Name of issuer: NanoString Technologies Inc. Title of Class of Securities: Common Stock CUSIP Number: 63009R109 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is

February 5, 2021 SC 13G/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)*

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* NanoString Technologies, Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 63009R109 (CUSIP Number) December 31, 2020 (Date of Event which Requires Filing of this Statement) Check the appropriate box to design

January 11, 2021 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 10, 2021 NanoString Technologies, Inc.

January 11, 2021 EX-99.1

NanoString Provides Preliminary Financial and Operational Highlights for Fourth Quarter and FY 2020 - Q4 Product and Service Revenue of $35.7 Million, Including GeoMx Revenue of $12.2 million, Exceeding High End of Guidance Ranges - - Over 180 Cumula

EX-99.1 2 nstg-8kex99101102021.htm EX-99.1 Exhibit 99.1 NanoString Provides Preliminary Financial and Operational Highlights for Fourth Quarter and FY 2020 - Q4 Product and Service Revenue of $35.7 Million, Including GeoMx Revenue of $12.2 million, Exceeding High End of Guidance Ranges - - Over 180 Cumulative GeoMx Orders as of Year End - SEATTLE - January 10, 2021 - NanoString Technologies, Inc.

January 11, 2021 SC 13G/A

SCHEDULE 13G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* NanoString Technologies Inc (Name of Issuer) Common Stock (Title of Class of Securities) 63009R109 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which

November 9, 2020 10-Q

Quarterly Report - 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File: Number 001-3598

November 9, 2020 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2020 NanoString Technologies, Inc.

November 9, 2020 EX-99.1

NanoString Technologies Releases Operating Results for Third Quarter of 2020

Exhibit 99.1 NanoString Technologies Releases Operating Results for Third Quarter of 2020 SEATTLE - November 9, 2020 - NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the third quarter of 2020. Third Quarter Financial Highlights •Product and service revenue of $30.1 million, 14% yea

October 9, 2020 SC 13G/A

NSTG / NanoString Technologies, Inc. / ARK Investment Management LLC - SC 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.

October 9, 2020 SC 13G/A

NSTG / NanoString Technologies, Inc. / Sumitomo Mitsui Trust Holdings, Inc. - AMENDMENT NO. 2 Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* NanoString Technologies, Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 63009R109 (CUSIP Number) September 30,2020 (Date of Event which Requires Filing of this Statement) Check the appropriate box to desi

October 8, 2020 424B5

CALCULATION OF REGISTRATION FEE

Filed Pursuant to Rule 424(b)(5) Registration No. 333-230361 CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to be Registered Amount to be Registered (1) Proposed Maximum Offering Price Per Unit Proposed Maximum Aggregate Offering Price Amount of Registration Fee (2) Common Stock, par value $0.0001 per share 5,750,000 $40.00 $230,000,000 $25,093 (1) Includes 750,000 shares that m

October 8, 2020 EX-1

Underwriting Agreement, dated as of October 7, 2020

NANOSTRING TECHNOLOGIES, INC. 5,000,000 Shares of Common Stock Underwriting Agreement October 7, 2020 J.P. Morgan Securities LLC UBS Securities LLC Cowen and Company, LLC As Representatives of the several Underwriters listed in Schedule 1 hereto c/o J.P. Morgan Securities LLC 383 Madison Avenue New York, New York 10179 c/o UBS Securities LLC 1285 Avenue of the Americas New York, New York 10019 c/o

October 8, 2020 8-K

Financial Statements and Exhibits, Other Events - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 7, 2020 NanoString Technologies, Inc.

October 8, 2020 SC 13G/A

NSTG / NanoString Technologies, Inc. / Nikko Asset Management Americas, Inc. - SC 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* NanoString Technologies, Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 63009R109 (CUSIP Number) September 30, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to desig

October 7, 2020 FWP

NANOSTRING TECHNOLOGIES, INC. Offering of Common Stock

Issuer Free Writing Prospectus Filed Pursuant to Rule 433 Registration No. 333-230361 Supplementing the Preliminary Prospectus Supplement dated October 6, 2020 (To Prospectus dated March 18, 2019) NANOSTRING TECHNOLOGIES, INC. Offering of Common Stock The information in this free writing prospectus relates only to the offering of common stock offered pursuant to our preliminary prospectus suppleme

October 6, 2020 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 6, 2020 NanoString Technologies, Inc.

October 6, 2020 424B5

Per share Total Public offering price $ $ Underwriting discounts and commissions(1) $ $ Proceeds, before expenses, to us $ $

Subject to completion, dated October 6, 2020 The information in this preliminary prospectus supplement is not complete and may be changed.

October 6, 2020 EX-99

NanoString Technologies Provides Preliminary Financial and Operational Highlights for Third Quarter 2020 - Third Quarter Product and Service Revenue of $30.1 Million vs. Guidance Range of $25 to $28 Million - - More than 25 New GeoMx DSP Orders Recei

Exhibit 99.1 NanoString Technologies Provides Preliminary Financial and Operational Highlights for Third Quarter 2020 - Third Quarter Product and Service Revenue of $30.1 Million vs. Guidance Range of $25 to $28 Million - - More than 25 New GeoMx DSP Orders Received in the Third Quarter - SEATTLE - October 6, 2020 - NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science to

August 10, 2020 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 10, 2020 NanoString Technologies, Inc.

August 10, 2020 10-Q

Quarterly Report - 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File: Number 001-35980 NAN

August 10, 2020 SC 13G

NSTG / NanoString Technologies, Inc. / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* NanoString Technologies Inc (Name of Issuer) Common Stock (Title of Class of Securities) 63009R109 (CUSIP Number) July 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this

August 10, 2020 EX-99.1

NanoString Technologies Releases Operating Results for Second Quarter of 2020

Exhibit 99.1 NanoString Technologies Releases Operating Results for Second Quarter of 2020 SEATTLE - August 10, 2020 - NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the second quarter of 2020. Second Quarter Financial Highlights •Product and service revenue of $21.1 million, 5% ye

June 19, 2020 8-K

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 16, 2020 NanoString Technologies, Inc.

June 1, 2020 EX-1.01

Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form.

EX-1.01 2 nstgex101.htm EXHIBIT 1.01 Exhibit 1.01 NANOSTRING TECHNOLOGIES, INC. Conflict Minerals Report For the Year Ended December 31, 2019 This report for the year ended December 31, 2019 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934, as modified by SEC guidance issued on April 29, 2014 and the SEC order issued on May 2, 2014 (the “Rule”). The Rule was adopted

June 1, 2020 SD

- SD

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM SD Specialized Disclosure Report NanoString Technologies, Inc.

May 8, 2020 10-Q

Quarterly Report - 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File: Number 001-35980 NA

May 7, 2020 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2020 NanoString Technologies, Inc.

May 7, 2020 EX-99.1

NanoString Technologies Releases Operating Results for First Quarter of 2020

Exhibit 99.1 NanoString Technologies Releases Operating Results for First Quarter of 2020 SEATTLE - May 7, 2020 - NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the first quarter of 2020. First Quarter Financial Highlights • Product and service revenue of $24.5 million, 15% year-ov

April 27, 2020 DEFA14A

- DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a party other than the Registrant ¨ Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)

April 27, 2020 DEFA14A

- DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a party other than the Registrant ¨ Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)

April 27, 2020 DEF 14A

- DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)

April 6, 2020 EX-99.1

NanoString Provides COVID-19 Business Update and Announces Conference Call on Thursday May 7th, 2020 GeoMx DSP Orders and Revenue In-Line with Prior Guidance nCounter Instrument and Consumable Revenue Disrupted by COVID-19

Exhibit 99.1 NanoString Provides COVID-19 Business Update and Announces Conference Call on Thursday May 7th, 2020 GeoMx DSP Orders and Revenue In-Line with Prior Guidance nCounter Instrument and Consumable Revenue Disrupted by COVID-19 SEATTLE - (Business Wire) April 6, 2020 - NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational rese

April 6, 2020 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 6, 2020 NanoString Technologies, Inc.

March 20, 2020 8-K

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 16, 2020 NanoString Technologies, Inc.

March 20, 2020 EX-16.1

Letter from PricewaterhouseCoopers LLP to the Securities and Exchange Commission dated March 20, 2020.

Exhibit 16.1 March 20, 2020 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We have read the statements made by NanoString Technologies, Inc. (copy attached), which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 4.01 of Form 8-K of NanoString Technologies, Inc. dated March 16, 2020. We agree with the statements co

March 9, 2020 EX-99.1

NanoString Technologies Announces Proposed Private Offering of $175 Million of Convertible Senior Notes

EX-99.1 3 d890689dex991.htm EX-99.1 Exhibit 99.1 NanoString Technologies Announces Proposed Private Offering of $175 Million of Convertible Senior Notes SEATTLE, Wash. – March 4, 2020 – NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced that it intends to offer, subject to market conditions and other factors, $175 milli

March 9, 2020 EX-99.2

NanoString Technologies Announces Pricing of Upsized Offering of $200 Million of Convertible Senior Notes

EX-99.2 Exhibit 99.2 NanoString Technologies Announces Pricing of Upsized Offering of $200 Million of Convertible Senior Notes SEATTLE, Wash. – March 5, 2020 – NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced the pricing of $200 million aggregate principal amount of 2.625% convertible senior notes due 2025 in a privat

March 9, 2020 EX-4.1

Indenture, dated March 9, 2020, between NanoString Technologies, Inc. and U.S. Bank, National Association.

EX-4.1 2 d890689dex41.htm EX-4.1 Exhibit 4.1 NANOSTRING TECHNOLOGIES, INC. AND U.S. BANK NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of March 9, 2020 2.625% Convertible Senior Notes due 2025 TABLE OF CONTENTS PAGE ARTICLE 1 DEFINITIONS Section 1.01. Definitions 1 Section 1.02. References to Interest 13 ARTICLE 2 ISSUE, DESCRIPTION, EXECUTION, REGISTRATION AND EXCHANGE OF NOTES Section 2.01

March 9, 2020 8-K

Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 4, 2020 NanoString Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35980 20-0094687 (State or other jurisdiction of incorporation) (Co

March 3, 2020 S-8

NSTG / NanoString Technologies, Inc. S-8 - - S-8

As filed with the Securities and Exchange Commission on March 2, 2020 Registration No.

March 2, 2020 EX-10.21

Amendment to Employment Agreement dated February 27, 2020, between the Registrant and Joseph Beechem.

EX-10.21 6 nstg-ex1021.htm EXHIBIT 10.21 Exhibit 10.21 NANOSTRING TECHNOLOGIES, INC. AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT This Amendment to Executive Employment Agreement (this “Amendment”) is made by and between Joseph Beechem (“Executive”) and NanoString Technologies, Inc., a Delaware corporation (the “Company” and together with Executive, the “Parties”) on the dates set forth below. WHER

Other Listings
DE:0F1
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista